Skip to main content
. 2020 Feb 6;63(3):151–158. doi: 10.1002/jlcr.3828

Table 3.

Summary of the specifications used for the cGMP radiosynthesis of [11C]UCB‐J for multi dose vials

QC Test (Parameter/Method) Release Criteria Production 1 Production 2 Production 3
Appearance Clear colourless solution Confronts Confronts Confronts
pH 4.5‐8.5 6.4 6.1 6.1
HPLC system suitability test Retention time difference less than 8 s in two injections of reference solution pass pass pass
Radiochemical identity Retention time of [11C]UCB‐J corresponds to that of reference UCB‐J standard, corrected for the dead‐volume between UV and radio‐detector pass pass pass
Chemical amount of UCB‐J ≤10 μg/dose 8.8 8.6 6.8
Chemical amount of desmethyl UCB‐J ≤1.5 μg/dose 0.97 0.59 0.6
Chemical amount of unidentified impurity ≤1.5 μg/dose 1.44 1.38 1.00
Total unidentified impurity ≤3.0 μg/dose 2.40 2.29 2.00
Radiochemical purity of [11C]UCB‐J ≥95% 100 100 100
Molar activity (GBq/μmol) N/A 33.0 23.4 32.1
Strength (MBq in 0.1 mL) N/A 9.1 6.3 6.8
Bacetiral endotoxins (postrelease test) ≤175 EU/dose (≤17.5 EU/mL) ≤2.5 EU/mL ≤2.5 EU/mL ≤2.5 EU/mL
Filter integrity (postrelease test) Bubble point ≥46 psi (3.17 bar) 3.8 bar 3.7 bar 3.8 bar
Sterility (postrelease test) Pass test pass pass pass
Residual solvent DMF (postrelease test) ≤0.88 μg/day (≤880 ppm) ND ND 1.5
Formulation solvent EtOH (postrelease test) ≤10% 7.7% 9.8% 10%

Note. The limits are per injected dose. The desmethyl UCB‐J competes with UCB‐J for the binding site for which reason the specification for desmethyl UCB‐J is stringent. The unidentified impurities include all impurities in the final formulated product, and they were calculated using 258 nm wavelength absorbance response.